MRKR Annual Shareholders Equity
$14.05 M
-$5.55 M-28.31%
31 December 2023
Summary:
As of January 23, 2025, MRKR annual stockholders equity is $14.05 million, with the most recent change of -$5.55 million (-28.31%) on December 31, 2023. During the last 3 years, it has fallen by -$13.29 million (-48.61%). MRKR annual shareholders equity is now -76.32% below its all-time high of $59.34 million, reached on December 31, 2018.MRKR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRKR Quarterly Shareholders Equity
$7.45 M
-$2.25 M-23.22%
30 September 2024
Summary:
As of January 23, 2025, MRKR quarterly stockholders equity is $7.45 million, with the most recent change of -$2.25 million (-23.22%) on September 30, 2024. Over the past year, it has dropped by -$2.25 million (-23.22%). MRKR quarterly shareholders equity is now -89.72% below its all-time high of $72.49 million, reached on March 31, 2021.MRKR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRKR Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.3% | -23.2% |
| 3 y3 years | -48.6% | -23.2% |
| 5 y5 years | -76.3% | -78.4% |
MRKR Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -68.0% | at low | -83.1% | at low |
| 5 y | 5-year | -68.1% | at low | -89.7% | at low |
| alltime | all time | -76.3% | +165.8% | -89.7% | +129.0% |
Marker Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.45 M(-23.2%) |
| June 2024 | - | $9.70 M(-17.7%) |
| Mar 2024 | - | $11.79 M(-16.1%) |
| Dec 2023 | $14.05 M(-28.3%) | $14.05 M(-15.9%) |
| Sept 2023 | - | $16.71 M(-12.2%) |
| June 2023 | - | $19.03 M(+19.6%) |
| Mar 2023 | - | $15.91 M(-18.8%) |
| Dec 2022 | $19.60 M(-55.4%) | $19.60 M(-13.3%) |
| Sept 2022 | - | $22.60 M(-19.4%) |
| June 2022 | - | $28.03 M(-21.5%) |
| Mar 2022 | - | $35.71 M(-18.8%) |
| Dec 2021 | $43.99 M(+60.9%) | $43.99 M(-15.9%) |
| Sept 2021 | - | $52.28 M(-17.3%) |
| June 2021 | - | $63.24 M(-12.8%) |
| Mar 2021 | - | $72.49 M(+165.1%) |
| Dec 2020 | $27.34 M(-38.0%) | $27.34 M(-10.6%) |
| Sept 2020 | - | $30.60 M(-11.3%) |
| June 2020 | - | $34.51 M(-12.6%) |
| Mar 2020 | - | $39.50 M(-10.4%) |
| Dec 2019 | $44.09 M(-25.7%) | $44.09 M(-7.9%) |
| Sept 2019 | - | $47.88 M(-6.9%) |
| June 2019 | - | $51.40 M(-7.6%) |
| Mar 2019 | - | $55.61 M(-6.3%) |
| Dec 2018 | $59.34 M(+1522.2%) | $59.34 M(+8493.9%) |
| Sept 2018 | - | $690.50 K(-83.3%) |
| June 2018 | - | $4.14 M(+572.8%) |
| Mar 2018 | - | $616.00 K(-83.2%) |
| Dec 2017 | $3.66 M(-40.9%) | $3.66 M(-38.4%) |
| Sept 2017 | - | $5.94 M(-30.7%) |
| June 2017 | - | $8.57 M(+106.9%) |
| Mar 2017 | - | $4.14 M(-33.0%) |
| Dec 2016 | $6.18 M(-129.0%) | $6.18 M(-17.5%) |
| Sept 2016 | - | $7.49 M(-138.8%) |
| June 2016 | - | -$19.33 M(-24.8%) |
| Mar 2016 | - | -$25.70 M(+20.3%) |
| Dec 2015 | -$21.36 M(+1986.8%) | -$21.36 M(+714.9%) |
| Sept 2015 | - | -$2.62 M(-73.3%) |
| June 2015 | - | -$9.81 M(+455.8%) |
| Mar 2015 | - | -$1.77 M(+72.5%) |
| Dec 2014 | -$1.02 M(-88.3%) | -$1.02 M(+56.0%) |
| Sept 2014 | - | -$656.20 K(-74.4%) |
| June 2014 | - | -$2.56 M(-53.5%) |
| Mar 2014 | - | -$5.51 M(-37.2%) |
| Dec 2013 | -$8.77 M(+45.1%) | -$8.77 M(+71.8%) |
| Sept 2013 | - | -$5.10 M(+7.0%) |
| June 2013 | - | -$4.77 M(-13.3%) |
| Mar 2013 | - | -$5.50 M(-9.0%) |
| Dec 2012 | -$6.04 M | -$6.04 M(+38.4%) |
| Sept 2012 | - | -$4.37 M(+14.4%) |
| June 2012 | - | -$3.82 M(+5.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | -$3.61 M(+4.2%) |
| Dec 2011 | -$3.46 M(-10.5%) | -$3.46 M(+59.0%) |
| Sept 2011 | - | -$2.18 M(+22.1%) |
| June 2011 | - | -$1.78 M(-23.4%) |
| Mar 2011 | - | -$2.33 M(-39.8%) |
| Dec 2010 | -$3.87 M(+514.4%) | -$3.87 M(+234.3%) |
| Sept 2010 | - | -$1.16 M(+175.7%) |
| June 2010 | - | -$419.60 K(-61.6%) |
| Mar 2010 | - | -$1.09 M(+73.6%) |
| Dec 2009 | -$629.40 K(-79.2%) | -$629.40 K(-17.2%) |
| Sept 2009 | - | -$760.40 K(-8.8%) |
| June 2009 | - | -$833.60 K(-75.6%) |
| Mar 2009 | - | -$3.41 M(+12.9%) |
| Dec 2008 | -$3.02 M(+80.5%) | -$3.02 M(+8.3%) |
| Sept 2008 | - | -$2.79 M(+9.1%) |
| June 2008 | - | -$2.56 M(+14.2%) |
| Mar 2008 | - | -$2.24 M(+33.7%) |
| Dec 2007 | -$1.67 M(-44.2%) | -$1.67 M(+26.8%) |
| Sept 2007 | - | -$1.32 M(+56.6%) |
| June 2007 | - | -$843.50 K(-41.4%) |
| Mar 2007 | - | -$1.44 M(-52.0%) |
| Dec 2006 | -$3.00 M(+35.2%) | -$3.00 M(+8.9%) |
| Sept 2006 | - | -$2.76 M(+18.3%) |
| June 2006 | - | -$2.33 M(+11.5%) |
| Mar 2006 | - | -$2.09 M(-5.8%) |
| Dec 2005 | -$2.22 M(-9.0%) | -$2.22 M(+10.2%) |
| Sept 2005 | - | -$2.01 M(+18.4%) |
| June 2005 | - | -$1.70 M(+35.3%) |
| Mar 2005 | - | -$1.26 M(-48.5%) |
| Dec 2004 | -$2.44 M(+279.1%) | -$2.44 M(+82.2%) |
| Sept 2004 | - | -$1.34 M(+37.1%) |
| June 2004 | - | -$976.90 K(+80.3%) |
| Mar 2004 | - | -$541.70 K(-15.8%) |
| Dec 2003 | -$643.70 K(-238.2%) | -$643.70 K(-6.2%) |
| Sept 2003 | - | -$686.50 K(+4.1%) |
| June 2003 | - | -$659.60 K(-930.7%) |
| Mar 2003 | - | $79.40 K(-83.0%) |
| Dec 2002 | $465.80 K(-729.5%) | $465.80 K(-267.7%) |
| Sept 2002 | - | -$277.80 K(-169.4%) |
| June 2002 | - | $400.40 K(-203.4%) |
| Mar 2002 | - | -$387.30 K(+423.4%) |
| Dec 2001 | -$74.00 K(-86.8%) | -$74.00 K(-56.7%) |
| Sept 2001 | - | -$170.90 K(+49.8%) |
| June 2001 | - | -$114.10 K(-34.3%) |
| Mar 2001 | - | -$173.60 K(-69.1%) |
| Dec 2000 | -$562.00 K(+297.5%) | -$562.00 K(+283.6%) |
| Sept 2000 | - | -$146.50 K(+520.8%) |
| June 2000 | - | -$23.60 K(-69.8%) |
| Mar 2000 | - | -$78.10 K |
| Dec 1999 | -$141.40 K | - |
FAQ
- What is Marker Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Marker Therapeutics?
- What is Marker Therapeutics annual shareholders equity year-on-year change?
- What is Marker Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Marker Therapeutics?
- What is Marker Therapeutics quarterly shareholders equity year-on-year change?
What is Marker Therapeutics annual stockholders equity?
The current annual shareholders equity of MRKR is $14.05 M
What is the all time high annual shareholders equity for Marker Therapeutics?
Marker Therapeutics all-time high annual stockholders equity is $59.34 M
What is Marker Therapeutics annual shareholders equity year-on-year change?
Over the past year, MRKR annual stockholders equity has changed by -$5.55 M (-28.31%)
What is Marker Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of MRKR is $7.45 M
What is the all time high quarterly shareholders equity for Marker Therapeutics?
Marker Therapeutics all-time high quarterly stockholders equity is $72.49 M
What is Marker Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, MRKR quarterly stockholders equity has changed by -$2.25 M (-23.22%)